SUMMARY The inhibitory effect of high and low molecular weight native and synthetic rat atrial peptides on oxygen consumption in isolated rat kidney mitochondria and slices was measured. Oxygen consumption by mitochondria was measured in the presence of succinate and/or adenosine diphosphate, furosemide, and low and high molecular weight native and synthetic rat atrial peptides. After the addition of succinate, adenosine diphosphate limiting respiration (State 4) increased in the presence of low, but not high, molecular weight native rat atrial peptides. Furosemide caused a significant decrease in State 4 respiration (p < 0.001). Angiotensin II and arginine vasopressin did not alter State 4 respiration. The rate of oxygen consumption after the addition of saturating adenosine diphosphate in the presence of saturating succinate (State 3 respiration) was reduced by low and high molecular weight native rat atrial peptides. Furosemide completely blocked oxygen consumption after the addition of adenosine diphosphate. Oxygen consumption was unchanged by trypsin treated (natriuretically inactive) low molecular weight rat atrial peptides and ventricular protein extracts of high and low molecular weight native rat atrial peptides. Synthetic and low molecular weight native rat atrial peptides had similar effects on mitochondrial oxygen consumption. Low molecular weight native and synthetic rat atrial peptides decreased the adenosine diphosphate to oxygen ratio, and these peptides, as well as furosemide, also induced mitochondrial swelling; none of the other rat atrial peptide combinations nor angiotensin II produced this effect. In kidney slices, basal oxygen consumption (without substrates) was stimulated by succinate. This succinate-stimulated oxygen consumption was inhibited when kidney slices were incubated with synthetic rat atrial peptides. Synthetic and native atrial peptides had indistinguishable inhibitory effects on renal oxygen consumption. Native rat atrial peptides and furosemide inhibited renal oxygen consumption and induced mitochondrial swelling. These events may be related to their rapid natriuretic effect. 8 Recently, several forms of rat (rAP) and human atrial peptides were sequenced, and though they differ in primary structure, each of the C-terminal peptides ex-
8 Recently, several forms of rat (rAP) and human atrial peptides were sequenced, and though they differ in primary structure, each of the C-terminal peptides ex-" 17 Their natriuretic effect appears to result from inhibition of sodium reabsorption in renal medullary collecting tubules and ducts, 18 -" but decreased renal vascular resistance also might be involved. 10 -20 The mechanism by which rAP induce natriuresis is unknown. Because concentrating sodium against a concentration gradient is an energy-requiring process, 21 a decrease in oxidative cellular metabolism in renal cells responsible for sodium retention would be expected to favor natriuresis. The site of oxidative energy production is the mitochondria. Specific metabolic inhibition of renal cells by the natriuretic drug furosemide (FU) was reported by Mohr, 22 who observed submicroscopic alterations of tubular epithelial mitochondria during peak diuresis after a single dose of FU. After diuresis, mitochondria were regenerated and enzyme activities returned to normal levels. To 492 HYPERTENSION VOL 7, No 4, JULY-AUGUST 1985 investigate a potential relationship between oxidative metabolism and natriuresis and diuresis for rAP, we compared the effects of FU with those of synthetic and native rAP on oxygen consumption (O,C) by kidney mitochondria and slices.
Methods

Chemicals, Drugs, and Atrial Peptides
Angiotensin II (ANG II), aprotinin, and bovine serum albumin were purchased from Sigma Chemical Corporation, St. Louis, MO, USA. Arginine vasopressin (AVP, Pitressin) was purchased from ParkeDavis, Morris Plains, NJ, USA, and FU was purchased from Elkins-Sinn, Inc., Cherry Hill, NJ, USA. Synthetic rat atriopeptin III (rAPIII) was purchased from Peninsula Laboratories, Inc., San Carlos, CA, USA.
Partially purified native rAP were prepared as described previously. 45 Briefly, atria were obtained from 200 male Sprague-Dawley rats, homogenized in I M acetic acid (10 ml/g of tissue), and centrifuged at 1200 x g for 10 minutes at 4°C. The pellet was homogenized, reextracted in one half the volume of acetic acid, and recentrifuged. The supernatants were combined and lyophilized. The lyophilized extract was homogenized in 1 M acetic acid and centrifuged, and the supernatant was fractionated on Sephadex G-75 eluted with 1 M acetic acid. High molecular weight rAP (HMW) were obtained from the 10,000-to 30,000-dalton fraction, and low molecular weight rAP (LMW) from the 3,000-to 10,000-dalton fraction. These fractions were lyophilized and dissolved in Krebs-Ringer bicarbonate buffer (KRBB) for bioassay of natriuretic activity and were tested for their effects on oxygen consumption by kidney slices and isolated kidney mitochondria. For HMW, 5.1 mg of protein was dissolved in 1.0 ml of KRBB and 0.1 ml added to incubation vials containing 3.0 ml final volume. For LMW, 3.0 mg of protein was dissolved in 3.8 ml of KRBB and 0.1 ml was also used. These amounts of HMW and LMW produced near maximum natriuresis (>400/^Eq/kgyi0 min) in anesthetized assay rats, 4 and had approximately equivalent natriuretic activity. In I1 assay rats weighing 175 ± 12 g ( ± S D ) , 210 fig of protein of HMW elicited a change in urinary sodium excretion of 145 ± 107 ju.Eq/kg/10 minutes from a control of 19 ± 17. By comparison, in 14 assay rats weighing 189 ± 11 g, 38 jug of protein of LMW increased urinary sodium excretion by 182 ± 119 ju.Eq/kg/10 minutes from 14 controls of 14 ± 10. A 2-/ig infusion of rAP III in 1.0 ml of phosphate buffered saline (8 x 10~7 M) produced a similar natriuresis in bioassay rats. Inactive (natriuretically) atrial extract was obtained by treating LMW with a suspension of bovine pancreatic trypsin coupled to agarose (Sigma) as previously described. 4 '
High (HMWV) and low (LMWV) molecular weight ventricular extracts were prepared according to the same procedures used for atrial extracts. The doses of HMWV and LMWV studied contained approximately the same amount of protein used for studies of their respective atrial extracts.
Preparation of Rat Kidney Mitochondria and Tissue Slices
Adult male Sprague-Dawley rats (360 ± 24 g) were killed by decapitation. Rat kidney mitochondria were prepared by a modification of the method of Weinbach. 23 Kidneys were rapidly removed and transferred to ice-cold 0.25 M sucrose. The kidneys were crushed in an ice-chilled cylindrical tissue press (Harvard Apparatus Co., Inc., Millis, MA, USA). Each gram of crushed tissue was added to 9 ml of ice-cold 0.25 M sucrose and homogenized for 2 minutes with a Teflon glass Potter-Elvejhem type homogenizer (Thomas Co., Philadelphia, PA, USA). The homogenates were centrifuged at 600 g for 10 minutes at 4°C. The supernatant was transferred to prechilled plastic tubes and centrifuged at 8500 g for 10 minutes. The crude mitochondrial pellet was washed three times with 2 ml of 0.25 M sucrose per gram of kidney tissue and finally suspended in 0.25 M sucrose (1 milligram per gram of tissue). The O,C of the mitochondria was measured within 1 hour of preparation.
Kidney slices were prepared from KRBB-perfused rat kidneys. After induction of pentobarbital anesthesia (50 mg/kg), a polyethylene catheter (PE-90) was inserted into the abdominal aorta immediately below the renal arteries. Subsequently, the aorta was clamped above the renal arteries, the left renal vein cut, and the proximal end of the aorta connected by the catheter to a 50-ml syringe in the infusion pump (Harvard Apparatus, Millis, MA, USA). Cold KRBB perfusion medium was infused at 7.64 ml/minute. Perfusion was continued until both kidneys were blanched. The kidneys were removed and immediately placed in ice-cold 0.9% saline. Kidneys were sliced sagittally with a Stadie-Riggs microtome (Thomas Co., Philadelphia, PA, USA), and the slices were placed in ice-chilled KRBB. Only center slices (125-175 mg wet weight) were used.
Oxygen Consumption
The O 2 C was measured polarographically with the method of Chance and Williams 24 with a Y.S.I. Model 53 biological oxygen monitor (Yellow Springs Instrument Co., Yellow Springs, OH, USA). For mitochondrial O 2 C, each incubation flask contained a final volume of 3 ml consisting of 75 mM KC1, 50 mM Tris-hydrochloride, 12.5 mM K,HPO 4 , 5 mM MgCl,, and 1 mM EDTA, pH 7.4 at 25°C. This medium was saturated with 95% O 2 , 5% CO, for 5 minutes before the addition of mitochondria, substrates, or substance being tested for the effect on O,C. A typical incubation mixture contained 2.4 ml of incubation buffer, 0.3 ml of mitochondria suspension, 0.1 ml of adenosine diphosphate (ADP, 250 /xM final concentration), 0.1 ml of succinate (7 mM final concentration), and 0.1 ml of test substance (e.g., rAP, ANG II). Control incubations contained 2.5 ml of incubation buffer and no test
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substance. The oxygen concentration before adding the mitochondrial suspension was calculated to be 250 jiM. 24 The slopes of the polarographic tracing (m,, m 2 , and m 3 ) were used to calculate the rate of O 2 C and were expressed as nanoliters of O 2 per milligram of protein per minute (see Figure 1 ). By definition, during State 4 respiration O 2 C is limited by ADP only, whereas during State 3 respiration O 2 C represents the capacity of the respiratory chain in the presence of saturating substrates.
24
Respiratory Control Index
The RCI was calculated from the ratio of State 3 to State 4 respiration. The RCI is an index of the tightness of coupling of O 2 C and phosphorylation in mitochondria. 24 Thus, RCI = State 3 (O 2 C nl/min/mg of protein)/State 4 (O 2 C nl/min/mg of protein), or as illustrated in Figure 1 (m^m,). The RCI values using succinate as a substrate range from 3 to 5 . . The recordei deflection X represents the total oxygen content of the reaction mixture, which was estimated to be 250 fiM. Microatoms of oxygen used = (Oxygen content of medium/X units) x Y units x 3 ml of reaction medium x 2. The ADP added per microatom of oxygen used = ADP:O ratio. The ADP:O ratio indicates the ability of mitochondria to conserve the energy produced by substrate oxidation in a form that can be used in the cell. 27 As one of the phosphorylation sites is bypassed with coupled succinate oxidation, the maximum ADP:O ratio attainable is 2.0. u In the present study, the mean range of RCI in control incubations was from 3.3 to 4.1 and the mean range of ADP:O ratio was from 1.76 to 2.00, both characteristic of well-preserved mitochondrial function.
To measure O 2 C in kidney slices, KRBB saturated for 5 minutes with 95% O 2 , 5% CO 2 was used. Two slices of kidney (250-350 mg wet weight) were placed in each flask containing a final volume of 3 ml, and O 2 C was measured as described. A typical incubation contained two kidney si ices, 2.9 ml of KRB B, and 0.1 ml of test substance. Kidney slices were preincubated in KRBB containing 2% bovine serum albumin, succinate (7 mM and 14 mM), aprotinin (50 /ig), and rAPIII (260 nM) at 37°C for 10 minutes. The kidney slices were then transferred to KRBB presaturated with 95% O 2 , 5% CO 2 for 5 minutes. The above proteins and rAPIII were then added again, and O 2 C was measured. Under these conditions O 2 C was linear for 5 minutes at 37°C. The O 2 C was expressed as microliters of O 2 per gram of wet tissue weight for 3 minutes.
Mitochondrial Swelling
Mitochondrial swelling was measured by following the change in absorbancy of the mitochondrial suspension at 520 nm in a Gilford spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, OH, USA) with a modification of the method of Lehninger and Neubert. 28 Swelling experiments were performed in 15-X 85-mm disposable culture tubes (American Hospital Supply Corporation, McGaw Park, IL, USA). The reaction was started by diluting 0.05 ml of the stock suspension of mitochondria (0.5 mg of mitochondrial protein) to 5.0 ml of 0.125 M KC1, 0.02 M Tris-hydrochloride medium at pH 7.3 that already contained the other additions (substances to be tested for their effect on swelling), previously adjusted to this pH at 25°C. The data are expressed in terms of the decline in absorbancy x 10 3 of mitochondria at 520 nm (i.e., -A log Io/I x 10 3 at 520 nm) produced by the swelling agent above the spontaneous swelling rate at 30 minutes. Protein concentrations in all experiments were determined by the method of Lowry et al. 29 
Statistics
Statistical comparisons between control and treated groups were analyzed by one-way (Tables 1-3) 
Results
Renal Mitochondrial Oxygen Consumption
Typical polarographic recordings of the O 2 C by isolated kidney mitochondria in the presence of substrates and test substances are shown in Figure 1 . In each set of experiments, control incubations (without test substance) were compared with separate incubations containing test substances (e.g., HMW, LMW, FU, etc.) using the same mitochondrial preparation. Sets were repeated with separate mitochondrial preparations. Doses of LMW (79 /xg protein) and HMW (210 /xg protein) produced equivalent, near maximum natriuresis bioassay rats. Preparations of LMWV, HMWV, and trypsin-treated LMW (LMWT) were tested for their effects on O 2 C using amounts of protein comparable to their natriuretically active counterparts. Basal O 2 C, with no substrates added, was minimal. The addition of saturating amounts of succinate and ADP increased O 2 C in an additive manner.
State 4 respiration was unchanged after the addition of HMW but increased after LMW (Table 1) . State 3 respiration was reduced in the presence of HMW and more so in the presence of LMW. The RCI remained unchanged after the addition of HMW but decreased when mitochondria were exposed to LMW. The mitochondrial ADP:O ratio decreased after exposure to LMW but was unchanged when exposed to HMW. In addition to completely blocking the O 2 C after adding ADP, FU administration also significantly decreased State 4 respiration (p < 0.001). There were no signifi- Values are means ± SD. The number of repetitions is indicated in parentheses. AVP = arginine vasopressin; ANG II = angiotensin II; ADP = adenosine diphosphate; FU = furosemide, HMW = high molecular weight rat atrial natriuretic peptides (rAP), HMWV = high molecular weight extract from rat ventricles; LMW = low molecular weight rAP; LMWV = low molecular weight extract from paired rat ventricles; LMWT = low molecular weight rAP treated with trypsin; RCI = respiratory control index; ADP • O = ADP to oxygen ratio. ) did not affect O 2 C (data not shown). Like ANG II, AVP also decreased State 3 respiration and the RCI. These AVP effects were observed at concentrations as low as 10-'M.
of mitochondria isolated from normal rat kidneys. (A) O 2 C incubated without additives. (B) O2C incubated with LMW. (C) O 2 C incubated with HMW. (D) O 2 C incubated with FU (4 mM). Incubations were in a final
Natriuretic doses of synthetic rAPIII were tested in this system. As seen in Table 2 , the O 2 C after the addition of saturating succinate increased after 5.2 x 10~7 M rAPIII was added. State 3 respiration was reduced by 2.6 x 10-7 M rAPIII. The RCI also decreased in the presence of rAPIII, and the mitochondrial ADP:0 ratio decreased after exposure to rAPIII.
Swelling of Mitochondria
As shown in Table 3 , rAPIII, LMW, and FU caused a profound mitochondrial swelling within 30 minutes, whereas HMW, LMWV, LMWT, and ANG U did not. This effect was rapid, being detectable between 5 and 10 minutes after the swelling agent was added (data not shown).
Oxygen Consumption of Kidney Slices Whereas LMW clearly affected O 2 C at the subcellular level, initially we were unable to demonstrate an effect of LMW or HMW on O 2 C in rat kidney slices. As native rAP did not change the O 2 C in kidney slices during a 3-minute observation, we investigated the effects of a longer period of exposure by preincubating slices with rAPIII under conditions designed to minimize proteolysis, as shown in Figure 2 . While basal •Synthetic rat APIII produced maximum natriuresis in bioassay rats (Lot No. 005642, MW 2550). tp < 0.05, %p < 0.001, using one-way analysis of variance between control and treatment groups.
TABLE 3. Effect of Test Substances on Swelling of Rat Kidney Mitochondria
Test substance Concentration -AOD(520nm x
Rat atriopeptin III (8) Native rat atrial peptide LMW (6) HMW (7) LMWV (8) LMWT (4) Furosemide (6) Angiotensin II (5 Values are means ± SD. The number of repetitions is indicated in parentheses. HMW = high molecular weight; LMW = low molecular weight; LMWT = trypsin treated LMW rat atrial peptides; LMWV = LMW ventricular protein extracts; OD = optical density.
*These doses of atrial peptide cause near equivalent maximum natriuresis in bioassay rats, tp < 0.001, using one-way analysis of variance between control and treatment groups. 0 2 C was inhibited by 3 mM FU (data not shown), it was unchanged by rAPIIl. This basal rate was stimulated in a dose-dependent manner in the presence of 7 mM succinate and 14 mM succinate. This stimulation was inhibited by rAPIIl (260 nM) in 7 mM succinate or in 14 mM succinate.
Discussion
In the present study, we found that rAP inhibited succinate stimulated O 2 C in kidney slices and inhibited State 3 respiration and decreased the ADP:O ratio in isolated kidney mitochondria. Synthetic rAPIIl showed effects on renal O 2 C indistinguishable from those of native LMW.
We found that atrial peptides, ANG II, and AVP inhibited mitochondrial State 3 respiration and reduced RCI. Infusions of synthetic atrial peptides produced detectable natriuresis at doses similar to those concentrations needed to inhibit renal O 2 C (i.e., 10~7 M). Snart 30 demonstrated a comparable potency for AVP when he observed that it produced maximal sodium transport in mitochondria at 10~9 M. In contrast, the dose of ANG II required to stimulate aldosterone synthesis appears to be much lower than that needed to produce the mitochondria] O 2 C inhibiting effects that we observed. 31 As the circulating level of ANG II is 10-9 M 31 and AVP is lO" 12 M, 32 the effects on mitochondrial O 2 C may not have been physiological, but hormone concentrations at intracellular mitochondrial sites could be higher. Although physiological levels of rAP have not been reported, the 10~7 M rAPIIl necessary to inhibit mitochondrial O 2 C also seems high.
From these experiments, it is not possible to decide whether the inhibitory effects we observed occur in renal vascular or renal tubular elements, and the sensitivity of the response may increase when preparations enriched in tubular or vascular cells are used. Interestingly, our laboratory recently observed that ANG II and AVP, but not norepinephrine, greatly potentiated the natriuretic activity of LMW. 33 The importance of structural differences in the atrial natriuretic peptides and their mechanisms of action in promoting renal sodium excretion have not been defined. An intact disulfide ring has been demonstrated to be essential for natriuretic activity." The C-terminal disulfide ring portion of human atrial peptides differs in one amino acid 8 from that of rAP, but it has natriuretic activity in the rat. 5 The importance of chain length also has not been established. Peptides of various lengths have been isolated from the same species, 8 and Forssmann et al. 34 have reported that part of the Nterminal sequence of the probable precursor peptide has vasorelaxant but not natriuretic activity. Currie et al. 35 reported that, in contrast to LMW, the HMW were relatively inactive when tested on smooth muscle preparations in vitro. Our finding that LMW were more active than HMW in affecting renal O 2 C at the mitochondrial level in vitro is consistent with these data. Several investigators have suggested a precursor-product relationship between HMW and LMW. 17 u -* Further, we have observed that HMW was converted to LMW by atrial extracts 37 and platelets. 38 Thus, to be active, HMW may require conversion to LMW, either during its release or in blood. The low activity of HMW in isolated mitochondria (shown in Table 1 ) may therefore represent a lack of sufficient conversion.
We compared the effects of FU and rAP on renal O 2 C because both rapidly induce a short natriuresis. As far as we know, their effects on renal O 2 C have not been compared in the same preparation previously. The rapid natriuretic effect of FU is more prolonged than that of rAP in rats. 3 To compare their effect on O 2 C (see Tables 1 and 2 ), we chose doses of FU, rAP, and rAPIIl that produced near maximum natriuresis in bioassay rats. We confirmed the observation that FU (3 mM) inhibited O 2 C in kidney slices, though less potently than that reported by other investigators, who observed O 2 C inhibition by 5.2 x I C M FU in potassium-free incubation media. 39 Further, 4 mM FU inhibited State 4 respiration but completely blocked O 2 C following ADP addition in isolated mitochondria. In contrast, 260 nM rAPIII-inhibited succinates stimulated O 2 C in kidney slices while 260 nM rAPIIl increased State 4 respiration in mitochondria. Like FU, rAPIIl inhibited State 3 respiration, but not completely. Thus, at doses needed to produce near equivalent maximum natriuresis, FU on a molar basis appears to be much less potent than rAP in inhibiting O 2 C. These data demonstrate differences between FU and rAP in potency and mechanism in inhibiting renal O 2 C.
As to the mechanism of action of these diuretics, the chloride-dependent Na-K cotransport system in erythrocytes in the presence of ouabain has been suggested as a model that can be used to study loop diuretics. 40 - 41 We have demonstrated that rAP has no effect on this furosemide-inhibited system. 42 Further, whereas FU inhibits Na + -K + -activated ATPase, 43 -44 rAP does not inhibit Na-K dependent ATPase from pork cerebral cortex, dog kidney, or rat renal medulla. 45 Our results provide evidence that FU and rAP inhibit mitochondrial O 2 C by clearly different mechanisms and induce mitochondrial swelling. Swelling of mitochondria, inhibition of O 2 C, and oxidative phosphorylation are related events.*• 47 Thus, FU and rAP through these actions, if they occur in vivo, would contribute metabolically to an adenosine triphosphate deficient state, a condition supportive of their observed natriuretic effects.
